Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program. - Matthews DR; Li Q; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Hiatt WR; Nehler M; Fabbrini E; Kavalam M; Lee M; et al. (Diabetologia, 2019)